E-resources
Peer reviewed
Open access
-
Mallardo, Domenico; Giannarelli, Diana; Vitale, Maria Grazia; Galati, Domenico; Trillò, Giusy; Esposito, Assunta; Isgrò, Maria Antonietta; D'Angelo, Grazia; Festino, Lucia; Vanella, Vito; Trojaniello, Claudia; White, Andrew; De Cristofaro, Teresa; Bailey, Michael; Pignata, Sandro; Caracò, Corrado; Petrillo, Antonella; Muto, Paolo; Maiolino, Piera; Budillon, Alfredo; Warren, Sarah; Cavalcanti, Ernesta; Ascierto, Paolo Antonio
Journal for immunotherapy of cancer, 11/2022, Volume: 10, Issue: 11Journal Article
BackgroundNivolumab is an anti-PD-1 antibody approved for treating metastatic melanoma (MM), for which still limited evidence is available on the correlation between drug exposure and patient outcomes.MethodsIn this observational retrospective study, we assessed whether nivolumab concentration is associated with treatment response in 88 patients with MM and if the patient’s genetic profile plays a role in this association.ResultsWe observed a statistically significant correlation between nivolumab serum concentration and clinical outcomes, measured as overall and progression-free survival. Moreover, patients who achieved a clinical or partial response tended to have higher levels of nivolumab than those who reached stable disease or had disease progression. However, the difference was not statistically significant. In particular, patients who reached a clinical response had a significantly higher concentration of nivolumab and presented a distinct genetic signature, with more marked activation of ICOS and other genes involved in effector T-cells mediated proinflammatory pathways.ConclusionsIn conclusion, these preliminary results show that in patients with MM, nivolumab concentration correlates with clinical outcomes and is associated with an increased expression of ICOS and other genes involved in the activation of T effectors cells.
Author
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.